Primary human fibroblasts undergoing oncogene-induced or replicative senescence are known to form senescence-associated heterochromatin foci (SAHF), which can stabilize the state of senescence. The retinoblastoma (RB) protein has an important role in SAHF; cells that lack active RB pathway fail to form SAHF. It has been known that the posttranslational modifications of RB, for example, phosphorylation, regulate its function. To date, whether methylation of RB impacts on the SAHF formation is unknown. Here we report that JMJD3, a histone demethylase catalyzing the tri-methylation of H3K27 (H3K27me3), can demethylate the nonhistone protein RB at the lysine810 residue (K810), which is a target of the methyltransferase Set7/9. We detected a significant upregulation of JMJD3 during cellular senescence and SAHF formation in WI38 cells induced by H-RasV 12 , and we found that ectopic expression of JMJD3 promoted cellular senescence and SAHF formation in WI38 cells. Furthermore, during the process of SAHF assembly, JMJD3 was transported to the cytoplasm and interacted with RB through its demethylase domain JmjC. Significantly, our data demonstrated that the JMJD3-mediated demethylation of RB at K810 impeded the interaction of RB with the protein kinase CDK4 and resulted in reduced level of phosphorylation of RB at Serine807/811 (S807/811), implicating an important role of the interplay between the demethylation and phosphorylation of RB in SAHF assembly. This study highlights the role of JMJD3 as a novel inducer of SAHF formation through demethylating RB and provides new insights into the mechanisms of cellular senescence and SAHF assembly. Cellular senescence is an irreversible process of cell cycle arrest. The senescent cells remain metabolically active but are unable to express genes required for cell proliferation.
Cellular senescence is an irreversible process of cell cycle arrest. The senescent cells remain metabolically active but are unable to express genes required for cell proliferation. 1, 2 The known causes of cellular senescence include telomere shortening, oxidative stress, DNA damage and hyperoncogenic signaling. 3 H-RasV 12 has been used as a model to induce senescence in normal cells. [4] [5] [6] Senescent cells are typically characterized by a large flat morphology and the expression of a senescence-associated β-galactosidase activity (SA-β-gal), and nuclei of senescence cells may remodel to form the heterochromatin structures termed the senescenceassociated heterochromatin foci (SAHF). 7 SAHF are condensed regions of DNA that correlate with transcriptionally inactive sites. 8 These heterochromatin foci are hallmarked by H3K9me3 and the incorporation of heterochromatin protein HP1, macroH2A, PML (promyelocy leukemia protein) and HMGA1 (high mobility group AT-hook 1). 7, [9] [10] [11] Recently, it has been shown that repressive markers, such as H3K9me3, H3K9me2 and H3K27me3, are rearranged into the nonoverlapping structural layers in SAHF. [12] [13] [14] Changes of heterochromatin organization generate a repressive chromatin environment that prevents transcription of genes that promote growth, thereby stabilize the state of senescence. 7, 15 The retinoblastoma (RB) tumor suppressor is an important senescence regulator, which is typically activated during senescence and enforces the expression of other senescence-inducing proteins. [16] [17] [18] RB protein has a specific E2F-binding domain to suppress E2F activity. 19, 20 Formation of SAHF coincides with the RB tumor suppressor to E2F-responsive promoters, accompanied with the stable repression of E2F target genes, such as CyclinE, PCNA, MCM4 and CyclinA. 21, 22 We found in our earlier study that the activation of RB pathway was necessary for SAHF formation in cancer cells, 23 and cell lines in which the RB pathway could not be activated failed to form SAHF. Recent studies show that RB can also repress transcription through targeting chromatin remodeling enzymes, for example, histone deacetylases and methyltransferases. 24 In addition, posttranslational modifications of RB also regulate its activity. Multiple sites of phosphorylation of RB have been identified, and the increased level of RB phosphorylation at S807/811 results in dissociation of E2F from RB and activates the transcription of genes required for DNA synthesis and cell cycle progression.
Apart from the phosphorylation, methylation of RB has emerged as an important modification in recent years; for example, three lysine residues (K810, K873 and K860) within the C-terminal domain of RB have been reported to be methylated. [25] [26] [27] Particularly, the methylation of K810 residue has been found to bring about variable effects on the function of RB. For instance, methylation of K810 by SET domain containing protein 7 (Set7/9) retains the hypophosphorylated status of RB and suppresses the cellular growth in U2OS cells. 28 Contrarily, the SMYD2-dependent methylation of RB at K810 promotes cell cycle progression in SW780 and RT4 cells. 29 The mechanistic details underlying these discrepancies remain unclear. Moreover, whether the methylation of RB impacts the SAHF formation has not been studied prior to this report. In this study, we focused on the effect of RB K810 methylation/demethylation on its function in SAHF formation in WI38 cells.
Jumonji domain containing 3 (JMJD3) is a histone demethylase that demethylates histone H3K27, 30 and it enhances gene expression by demethylating the repressive H3K27me3 at promoters and gene bodies. As reported, JMJD3 acts as a tumor suppressor through demethylating the H3K27me3 at INK4a/ARF locus, thus increasing the expression of p16 in human and mouse fibroblasts. 31, 32 JMJD3 has also been linked to the regulation of other biological processes, such as differentiation of embryonic stem cells and inflammatory responses in macrophages. JMJD3 is induced during differentiation of glioblastoma stem cells.
33
JMJD3 can also enhance the nuclear localization of p53 and thus regulate its function. 34 Moreover, JMJD3 interacts with chromatin modifiers independent of its demethylase activity, to stimulate transcription. 30, 35 However, whether JMJD3 can demethylate non-histone proteins has not been reported prior to this study.
Accumulating evidence has revealed a critical impact of crosstalk between different posttranslational modifications of proteins in various cellular processes. In this study, we present evidence that JMJD3 promotes SAHF formation by demethylating RB at K810, which reduce the level of phosphorylation of RB protein at S807/811, and this interplay promotes the formation of SAHF in WI38 cells. Our findings unravel a novel function of JMJD3 as an inducer of SAHF formation, through demethylating the non-histone protein RB.
Results
JMJD3 was required for SAHF formation in senescent WI38 cells. To facilitate the study on factors and epigenetic modifiers involved in cellular senescence and SAHF assembly, we first established a cellular model by applying the activated oncogene H-Ras (H-RasV 12 ) to induce senescence and SAHF in human diploid fibroblasts WI38. 7 Meanwhile, we detected a significant upregulation of JMJD3 mRNA and protein level in WI38 cells following H-RasV 12 infection for up to 7 days (Figures 1a and b) . To determine the functional role of JMJD3 in senescence and SAHF formation, we used the lentivirus-mediated system to silence the JMJD3 expression ( Figure 1c Figure S2) . Thus ectopic expression of JMJD3 is able to induce SAHF formation, and this function needs JMJD3's demethylase activity.
JMJD3 was localized to the cytoplasm in the process of SAHF formation. As a histone demethylase for H3 lysine27 (H3K27), JMJD3 is thought to exert its function in nucleus. Indeed, we detected apparently reduced levels of H3K27me3, H3K27me2 and H3K27me1 in nuclei during the process of H-RasV 12 -induced SAHF formation, as revealed by western blotting and confocal fluorescence microscopy ( Figure 3a,Supplementary Figure S3) . Meanwhile, the level of H3K9me3 was basically unchanged. Moreover, the H3K27me3 was present as a circular ring around the DAPI foci (Supplementary Figure S4) , a phenomenon also reported by Carr et al. 28 We then analyzed the distribution of JMJD3 upon the formation of SAHF, and interestingly, we detected the localization of JMJD3 to the cytoplasm (Figure 3b ). In addition, the JMJD3 distribution was colocalized with the Golgi protein GM130 (Supplementary Figure S5) . To further confirm this result, we prepared the nuclear and cytoplasmic protein extraction, respectively, for immunoblotting, and the results indicated that the JMJD3 level in cytoplasm was much higher than that retained in nuclei (Figure 3c ) upon H-RasV 12 -induction. This observation inspired us to hypothesize that JMJD3 may interact with and demethylate proteins in cytoplasm, in addition to its main function of demethylating H3K27 in nuclei, during cellular senescence. This speculation will be validated in the following experiments.
JMJD3 interacted with RB through its demethylase domain. We have reported previously that the RB protein is vital to SAHF formation in cancer cells. 23 In addition, methylation of RB have been shown to affect its function. 25 Therefore, we intended to determine whether JMJD3 interacted with RB. First, we examined the relationship between JMJD3 and RB by using the co-immunoprecipitation (CoIP) assay, and the results showed that the ectopically expressed His-JMJD3 and Flag-RB in HEK-293T cells (Figure 4a ), as well as the endogenous JMJD3 and RB in WI38 cells (Figure 4b ), were co-precipitated. Furthermore, the His-JMJD3H1390A mutant was able to interact with the Flag- Figure S6 . Next, we wanted to determine the domain of RB that directly interacted with JMJD3. Purified recombinant glutathione S-transferase (GST)-tagged RB protein from bacteria was pulled down with the cell lysate of HEK-293T cells that overexpressed JMJD3. The GST-pull-down experiments demonstrated that GST-RB, but not GST alone, interacted with JMJD3 ( Figure 4c ). The JmjC domain at the C-terminus has been identified as the only conserved catalytic domain of JMJD3, 36 as schematically illustrated in Figure 4d . Also, as mentioned above, the demethylase activity of JMJD3 was necessary for inducing cellular senescence (Figure 2b ). Therefore, we were intrigued to find out whether the JmjC was the interacting domain with RB. We purified GST-JmjC to pull down with RB, and the results indicated that the JMJD3 JmjC domain was able to interact with RB ( Figure 4e ).
RB as shown in Supplementary
To pinpoint the site(s) at the RB protein that interacts with JMJD3, we generated a series of truncated GST-tagged RB peptides, as indicated in Figure 4f , for pull-down experiments with JMJD3. As can be seen in Figure 4g , the fragment 659-840 at the C-terminus of RB interacted with JMJD3. We then purified the Flag-RB(659-840) in HEK-293 cells and pulled down with GST-JmjC to confirm that the 659-840 domain directly bound with JmjC ( Figure 4h ). Together, these data demonstrate that the 659-840 domain of RB directly interacts with the demethylase domain of JMJD3.
JMJD3 demethylated RB protein at lysine810 (K810). To test whether binding of JMJD3 on RB causes the demethylation of the protein, we first examined the methylation level of RB in cells induced to form SAHF by H-RasV 12 for up to 7 days, as we showed that the RB methylation level was reduced in this process, and so does the phosphorylation of RB S807/811 (Figure 5a ). Then we purified 3*Flag-RB(659-840) from exponentially growing HEK-293 cells that ectopically express 3*Flag-RB(659-840), incubated with GST-JmjC in vitro and immunoblotted with an antibody recognizing methylated lysine. We found that the level of methylation of RB was reduced (Figure 5b ), but the JmjC mut with a mutation of the demethylase activity could not demethylate RB(659-840) (Figure 5b ), indicating that the catalytic domain of JMJD3 was able to demethylate the RB(659-840) fragment.
It has been reported that the K810, K860 and K873 residues of RB are methylated in vivo. 25 The truncated peptide RB(659-840) shown to interact with JMJD3 described above comprises the K810 residue, and this encouraged us to speculate that K810 may be the site JMJD3 demethylates the RB protein. Set7/9 is a methyltransferase reported to methylate the K810 and K873 sites at the C-terminal region of RB. We then performed an in vitro methylation-demethylation assay to prove this speculation. Purified Flag recombinant Set7/9 was used to methylate RB(659-840), and then the methylated RB (659-840) was incubated with the demethylase domain GSTJmjC and GST-JmjC mut. As a result, we detected that JmjC reverted the Set7/9-mediated methylation by using anti-lys methylation antibody (Figure 5c ). Meanwhile, we performed an in vitro methylation-demethylation assay using S-adenosyl-L-[methyl- 3 H] methionine (GE Healthcare, Buckinghamshire, UK) as a methyl donor and visualized by fluorography to further confirm the demethylation of RB by JMJD3 (Figure 5d ). To provide evidence that JMJD3 demethylates the Set7/9-dependent methylation of RB at K810, we constructed a plasmid expressing the mutant of RB(659-840K810R), purified the mutant fragment and incubated with GST-JmjC. We found that, when the K810 site was mutated in RB(659-840), the fragment could not be demethylated by JmjC (Supplementary Figure S7) . This experiment manifested that only the K810 residue of RB(659-840) was demethylated by JMJD3. Next, we synthesized a peptide comprising the 18 amino acids of RB, in which the K810 was methylated (Sangon Biotech, Shanghai, China). We then showed that the methylated peptide was demethylated by JmjC but not by JmjC mut (Figure 5e ).
Further we wanted to examine whether the methylation of RB K810 was depressed in WI38 cells. We infected WI38 cells with Flag-RB and Flag-RB(K810R) and then treated with or without H-RasV 12 , precipitated with Flag and detected the level of methylation by an antibody recognizing the methylated lysine. The results demonstrated that the RB methylation level was decreased by H-RasV 12 ( Figure 5f ). When RB was mutated to RB(K810R), the methylation level of RB was lower than the wild type, and the methylation of RB(K810R) was not reduced by H-RasV 12 ( Figure 5f ). Next, we ectopically expressed a truncated mutation of RB (Flag-RB(659-840K810R)) to further confirm that the K810 of RB was demethylated during Rasinduced SAHF formation (Figure 5g) . Collectively, our data demonstrate that the residue K810 in the C-terminal region of RB can be demethylated by JMJD3.
Demethylation of RB K810 reduced the RB phosphorylation level. As the phosphorylation modification of RB critically influences its function, we were curious to find out whether the JMJD3-mediated RB K810 demethylation affected the RB phosphorylation to regulate the SAHF process. To prove this assumption, we assessed the phosphorylation level of RB S807/811 upon ectopic JMJD3 expression or knockdown of JMJD3 expression in WI38 cells. We showed that, when JMJD3 was overexpressed, the phosphorylation level of RB S807/811 was apparently reduced (Figure 6a) . Contrarily, knockdown of JMJD3 prevented this reduction of phosphorylation level of RB S807/811 induced by H-RasV 12 ( Figure 6b ). In addition, we ectopically expressed Flag-RB and Flag-RB(K810R) and detected the RB phosphorylation level, and we found that the phosphorylation of RB S807/811 was reduced when the lysine 810 was mutated to arginine (K810R); and ectopic expression of JMJD3 and H-RasV 12 treatment also decreased the phosphorylation of RB (Figure 6c ). These results indicated that when the RB K810 residue was demethylated (or unmethylated), the phosphorylation of RB To further investigate the details of the interplay between K810 methylation and S807/811 phosphorylation of RB, we examined the recruitment of CDK4, a phosphorylase of RB S807/811, onto the RB protein in WI38 cells infected with JMJD3 and sh-JMJD3. The results revealed that the binding of CDK4 to RB was apparently attenuated when JMJD3 was overexpressed (Figure 6d ), while this interaction was reinforced when JMJD3 was knocked down (Figure 6e) .
We then explored whether mutation of the K810 residue had an impact on the expression of the E2F target genes. The realtime qPCR results showed that expression of wild-type RB (phosphorylated RB) was able to upregulate the E2F target genes CyclinA1, CCNA2 and CyclinB1, whereas the mutant RB(K810R) (unphosphorylated RB) could downregulate (Figure 6h) . Collectively, these experiments provided evidence that the demethylation (or low methylation) at RB K810 was accompanied by a concomitant dephosphorylation of RB S807/811, and this resulted in the promotion of SAHF formation.
Discussion
Senescent cells retain a stable repressive state of genes that are essential for cell cycle progression. In some senescent cells, heterochromatin is condensed to form the SAHF, which suppress the transcription of genes and stabilize the senescent state of the cells. 7 Elucidation of the molecular events involved in SAHF assembly provides an insight into the mechanisms of cellular senescence. Moreover, formation of SAHF in tumor cells helps to stabilize the senescence state induced by anticancer drugs; and this has emerged as a potential therapeutic strategy with the benefit of using considerably lower doses of the drugs and hence the much reduced side effects. It is for these reasons that SAHF has attracted a great deal of research interest in recent years. In this study, we have justified a novel function of the epigenetic modifier JMJD3 to demethylate the non-histone protein RB, which has been implicated as an important player in SAHF formation. JMJD3 is a key histone demethylase having various roles in cellular processes, for example, it demethylates the H3K27me3 at the p16 Ink4a promoter to activate the gene and thus to promote cellular senescence. 31 Earlier studies have indicated that RB is essential for SAHF formation and for the silencing of E2F target genes. 7 Our previous study demonstrates that the activated RB is also necessary for SAHF formation in tumor cells and this process is p16 independent. 23 In a preparatory experiment of this study, we found that JMJD3 was able to induce senescence in breast cancer MDA-MB-231 cells (Supplementary Figure S2) . As the MDA-MB-231 cell line is p16 deficient, there must be other mechanisms than the p16 pathway that JMJD3 participates in cell senescence and SAHF assembly.
Initially, we suspected that JMJD3 may work as a histone demethylase at H3K27me3 to induce SAHF formation. We examined the overall level of H3K27 methylation in senescent WI38 cells induced by H-RasV 12 ; and indeed, we detected an apparent decrease in the methylation of H3K27 (me1, me2 and me3) upon H-RasV 12 induction (Figure 3a) . Interestingly, we observed a JMJD3 accumulation in cytoplasm in the process of SAHF formation (Figure 3b ). In addition, the cytoplasmic JMJD3 appeared to be distributed to the Golgi complex where many proteins are posttranslationally modified, and the JMJD3 protein was colocalized with the Golgi protein GM130 (Supplementary Figure S5) . These results made us to speculate that JMJD3 may function at Golgi complex to modify non-histone proteins to participate in SAHF formation. Although JMJD3 is known to exert its function as an epigenetic modifier for histone H3K27, the possibility that it demethylates non-histones also exists. It has been reported that PRMT5 (protein arginine methyltransferase 5) can methylate the GM130 protein in Golgi complex. 37 We then intended to identify the cytoplasmic proteins that potentially interact with JMJD3. Most proteins known to have function in SAHF assembly are located in nucleus, for example, Suv39H1 and HP1γ. Nevertheless, the RB protein, a central regulator in senescence pathway, has been shown to be present both in the nucleus and in the cytoplasm 7 ( Figure 6h ). Therefore we focused on the investigation of whether RB protein is a target of JMJD3 in the cytoplasm in SAHF formation.
The RB/E2F pathway is vital for tumor suppression. It is well known that, in early G1 phase, RB is phosphorylated at S807/811 by CyclinD/CDK4/6, and the phosphorylated RB is released from E2F to activate genes required for cells to enter into S phase, while in senescent cells the RB S807/811 are dephosphorylated. 18, 38, 39 Inspired by the recent discovery that the posttranslational modifications of RB, such as phosphorylation, methylation and acetylation, may affect the RB function in regulating cellular activities, we were interested in investigation of the possible crosstalks of different modifications of RB in SAHF formation. A major finding of this study is that demethylation of RB also impacts SAHF formation and that JMJD3 acts as a cofactor in RB/E2F pathway. Significantly, we have provided evidence that the JMJD3-mediated demethylation of RB K810 impairs the phosphorylation of RB by suppressing the binding of CDK4 to RB, and this reduces the level of RB phosphorylation at S807/811 (Figure 6d) . Furthermore, the hypophosphorylated RB resulted from this crosstalk of modifications potentiates the interaction between RB and E2F, which in turn represses the expression of E2F target genes, such as MCM4, CyclinA1, CCNA2 and CyclinB1 (Figure 6f) . Interestingly, other E2F target genes, including MCM3, PCNA and DHFR, were not reduced by RB(K810R) mutant in contrast to the vector (Figure 6f) . Presumably, repression of CyclinA1, CCNA2 and CyclinB1 genes finally blocks the cell cycle progression and induces cellular senescence and SAHF formation in WI38 cells (Figure 6h ). This has been the first piece of evidence that the crosstalk between methylation/demethylation and phosphorylation of RB protein at specific residues regulates its function in SAHF formation.
Earlier studies have demonstrated that methylation at RB K810 by Set7/9 retains the hypophosphorylated state of RB and suppresses cellular growth in U2OS cells, 28 whereas the SMYD2-dependent methylation of RB K810 promotes cell cycle progression in SW780 and RT4 cells. 29 Apparently, our results are in favor of that described by Cho et al. 29 that methylation of RB K810 promotes cell cycle progression.
To summarize, we have proposed a working model to depict the JMJD3 function in regulation of cellular senescence and SAHF assembly, based on data arising from this study, as well as on other relevant information (Figure 7) . Briefly, this model illustrates that in normal growing cells RB is phosphorylated by CDK4, resulting in the release of the transcription factor E2F and hence the activation of the transcription of its target genes. This finally promotes the cell cycle progression and proliferation (Figure 7, upper) . On the other hand, when cells are exposed to the senescence signals, for example, the oxidative stress, DNA damage or hyperoncogenic pressure and so on, JMJD3 demethylates RB at K810, preventing CDK4 from binding. This reduces the level of phosphorylation of RB at S807/811 and induces senescence and SAHF formation (Figure 7, lower) . Overall, this study justifies the novel function of the histone demethylase JMJD3 as a promoting factor of the SAHF formation in senescent WI38 cells, through influencing the RB/E2F pathway. These findings provide new insights into the mechanisms of cellular senescence and SAHF assembly. Plasmids. The MSCV-JMJD3 and MSCV-JMJD3 H1390A retroviral expression plasmids were bought from Addgene (Cambridge, MA, USA). The His-JMJD3 expression plasmids and the bacterial expression plasmid pGEX-4T1-JmjC were gifts from Dr. Charlie Degui Chen (State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences). The JMJD3 cDNA (3991-4506) was generated by PCR to construct GST-JmjC domain of JMJD3. The lentiviral expression plasmid Pwpxld-Flag-RB and Pwpxld-Flag-RB(K810R) were constructed by inserting a PCR amplification fragment into the Pwpxld vector. For lentiviralmediated gene silencing, the shJMJD3#1, shJMJD3#2 and shJMJD3#3 oligonucleotides were designed to target human genes and were cloned into the pDSL-hpUGIP vector. The sequences of the shRNAs are listed as follows.
ShCtrl: 5′-GATCCCCTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACG TTCGGAGAATTTTTC-3′ and 5′-TCGAGAAAAATTCTCCGAACGTGTCACGTTCT CTTGAAACGTGACACGTTCGGAGAAGGG-3′;
shJMJD3#1: 5′-GATCCCCGCATCTATCTGGAGAGCAATTCAAGAGATTGCTCT CCAGATAGATGCTTTTTC-3′ and 5′-TCGAGAAAAAGCATCTATCTGGAGAGCAA TCTCTTGAATTGCTCTCCAGATAGATGCGGG-3′;
shJMJD3#2: 5′-GATCCCCGGAATGAGGTGAAGAACGTTTCAAGAGAACGTTC TTCACCTCATTCCTTTTTC-3′ and 5′-TCGAGAAAAAGGAATGAGGTGAAGAACG TTCTCTTGAAACGTTCTTCACCTCATTCCGGG-3′;
shJMJD3#3: 5′-GATCCCCGCAAGTGTGGAACTTGCTACATTCAAGAGATGTAG CAAGTTCCACACTTGCTTTTTC-3′ and 5′-TCGAGAAAAAGCAAGTGTGGAACTT GCTACATCTCTTGAATGTAGCAAGTTCCACACTTGCGGG-3′.
The bacterial expression plasmid pGEX-4T1-RB and the other truncated mutation were gifts from Dr. Julien Sage (the Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA). 3*flag-pCMV-RB (659-840) and 3*flag-pCMV-RB (659-840)K810R were constructed from the pGEX-4T1-RB (659-840) expression vector by inserting a PCR amplification fragment.
DAPI staining. For SAHF detection, cells were plated on cover slips. After infected to express H-RasV 12 for the indicated days, cells were fixed in 1% formaldehyde in PBS for 10 min at 37°C and permeabilized with 0.2% Triton X-100 in PBS for 10 min at room temperature. Cells were then washed three times in PBS and incubated with 500 nM DAPI (Invitrogen, Paisley, UK). Cells were documented using a charge-coupled device camera (Canon, Tokyo, Japan) attached to a microscope (OLYMPUS, Tokyo, Japan).
Cellular immunofluorescence. Cells were fixed in 1% formaldehyde in culture medium for 10 min at 37°C and permeabilized with 0.2% Triton X-100 in PBS for 10 min at room temperature. Cells were washed twice in PBS and blocked for 1 h with 5% BSA in PBS and then incubated with primary antibodies for 1 h at room temperature, washed three times in PBS and incubated with secondary antibodies for 50 min at room temperature. Photographs were taken using a confocal microscope (OLYMPUS). The primary antibodies were rabbit antiH3K9me3 (Millipore), rabbit anti-JMJD3 (Abcam), rabbit anti-H3K27me3 (Millipore) and mouse anti-HMGA1 (Santa Cruz).
Detection of SA-β-gal. Cells were fixed in 1% formaldehyde, washed three times with PBS (pH 6.0) containing 1 mM MgCl 2 and exposed overnight at 37°C to a solution containing 1 mg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside, 0.12 mM potassium ferrocyanide, 0.12 mM potassium ferricyanide and 1 mM MgCl 2 PBS buffer (pH 6.0). Cells were observed under a fluorescence microscope (OLYMPUS). All the experiments were repeated three times, and one of the representative results is shown.
BrdU incorporation assay. For the DNA synthesis assay, BrdU (BD Pharmingen, BD Biosciences) was added to the medium (10 nmol/ml) at the indicated time points, and cells were cultured for an additional 24 h. Cells were then fixed, permeabilized and denatured. BrdU incorporation was measured by immunofluorescence using an anti-BrdU serum (BD Pharmingen), and the nuclei were stained with DAPI. The stained cells were visualized under a fluorescence microscope, and at least 200 cells were scored for BrdU incorporation. Each experiment was repeated at least three times, and the results are displayed as a percentage of BrdU-positive cells in histogram.
Co-IP assay. Total cell extraction was precleared with salmon sperm DNA/ protein A/G-agarose beads (Millipore). Mouse anti-Flag and mouse anti-His was added for immunoprecipitation. The precipitates were then subjected to SDS/PAGE followed by transfer onto a PVDF membrane and incubation with anti-His or Flag serum. Samples were detected using the Super Signal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL, USA) detection method in accordance with the manufacturer's instructions.
GST pull-down assay. GST or GST fusion proteins were expressed in bacteria induced with isopropyl-β-D-thio-galactoside and purified. Equal amounts of GST or GST fusion proteins were incubated with glutathione-Sepharose 4B beads (GE Healthcare) and then washed three times with TEN buffer (20-mM Tris at pH 7.4, 0.1 mM EDTA and 100 mM NaCl). 40 Flag fusion proteins purified from HEK-293T cells was incubated with GST or GST fusion proteins. The beads were washed three times with TENT buffer (0.5% Nonidet P-40, 20 mM Tris at pH7.4, 0.1 mM EDTA and 300 mM NaCl) and analyzed by western blotting with anti-Flag or anti-GST antibody.
In vitro methylation and demethylation assay. To perform in vitro methylation assay, purified Flag-Set7/9 in HEK-293T cells were incubated with recombinant GST-RB (residues 659-840) as a substrate and 2 mCi S-adenosyl-L-[methyl-3H] methionine (GE Healthcare) as a methyl donor in a mixture of 10 ml of methylase activity buffer (20 mmol/l Tris-HCl, 4 mmol/l EDTA, at pH 8.0), for 1 h at 30°C. After methylation, 40 nmol 5'-deoxy-5'-(methylthio) adenosine (Sigma) was added to stop the methylase activity. The substrate was incubated with the purified fusion protein of GST-JmjC domain of JMJD3 in demethylation buffer (20 mM TrisHCl pH 7.3, 150 mM NaCl, 50 μM (NH 4 )2Fe(SO 4 )2+6(H 2 O), 1 mM α-ketoglutarate and 2 mM ascorbic acid) for 4 h at 37°C. 36, 41 Substrate was reacted in a total volume of 40 μl of reaction mixture. The reaction was stopped with SDS loading buffer, and western blotting analysis was performed. The sequence of the synthetized K810 methylated peptide (Sangon Biotech) is GGNIYISPLK(monomethy)SPYKISEG.
Cytoplasmic and nuclear extracts. Cells were collected, gently resuspended in 500 μl cytoplasmic extract buffer (10 mM HEPES, 60 mM KCl, 1 mM EDTA, 0.075% (v/v) NP40, 1 mM DTT and 1 mM PMSF, adjusted to pH 7.6) and incubated on ice for 30 min. Cells were then centrifuged at 14 000 r.p.m. for 1 min at 4°C, and the supernatant was transferred and saved. The nuclear pellets were resuspended in 100-200 μl nuclear extract buffer (20 mM Tris Cl, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM PMSF and 25% (v/v) glycerol, adjusted to pH 8.0) for 30 min on ice with vortexing. The extracts were centrifuged at 14 000 r.p.m. for 15 min at 4°C, and the supernatant (nuclear fraction) was transferred to a clean microcentrifuge tube.
Statistics. Data are presented as mean ± S.D. as indicated. Student's t-test (two-tailed) was used to determine statistic significance of differences between groups. Po0.05 was considered statistically significant. All statistical analyses were carried out using the SPSS 17.0 statistical software (SPSS software, Chicago, IL, USA).
